Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1300 of 3546 entries
View as:

A Study to Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Phase: N/A Priority: Normal
NCT ID: NCT02447432 Org: User:
Start: 06/11/15 End: 05/22/16 Due: 05/22/17

Evaluation of GW406381 in Treating Adults With Osteoarthritis Of The Knee

Phase: N/A Priority: Normal
NCT ID: NCT00120900 Org: User:
Start: 05/31/05 End: 09/30/07 Due: 09/30/08

Implementing Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals in Mexico

Phase: N/A Priority: Normal
NCT ID: NCT00436358 Org: User:
Start: 04/30/07 End: 01/31/08 Due: 01/31/09

An Open-Label Pharmacodynamic Study of Bevacivumab and Pazopanib in Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00992121 Org: User:
Start: 11/18/09 End: 11/01/13 Due: 11/01/14

A Clinical Study to Evaluate the Efficacy of Three Dry Mouth Relief Products Versus Water

Phase: N/A Priority: Normal
NCT ID: NCT03494985 Org: User:
Start: 09/17/13 End: 01/10/14 Due: 01/10/15

This Record Contains Information About the Mepolizumab Compassionate Use (CU) Product Activities: 104317: CU and Long-Term Access Study of Mepolizumab in HES. 201956:A Long-term Access Programme for Subjects With Severe Asthma 112562: Expanded Access for Patients With Hypereosinophilic

Phase: N/A Priority: Normal
NCT ID: NCT00244686 Org: User:
Start: - End: - Due: -

A Study for GSK3862995B in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease

Phase: N/A Priority: Normal
NCT ID: NCT06154837 Org: User:
Start: 11/27/23 End: 06/26/26 Due: 06/26/27

A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris

Phase: N/A Priority: Normal
NCT ID: NCT01915732 Org: User:
Start: 04/30/13 End: 04/30/14 Due: 04/30/15

Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)

Phase: N/A Priority: Normal
NCT ID: NCT06497504 Org: User:
Start: 09/17/24 End: 04/27/27 Due: 04/27/28

Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT00996671 Org: User:
Start: 11/06/09 End: 03/17/10 Due: 03/17/11

A Second Open-Label Extension of a Double-Blind, Parallel, Phase IV Study to Assess the Efficacy and Safety of Adjunctive Lovaza® (Formerly Known as Omacor®) Therapy in Hypertriglyceridemic Subjects Treated With Antara™

Phase: N/A Priority: Normal
NCT ID: NCT00891293 Org: User:
Start: 03/31/06 End: 05/31/08 Due: 05/31/09

Safety and Immunogenicity of GSK Bio's Candidate HBV-MPL Vaccines Compared to Engerix™-B, in Healthy Adolescents

Phase: N/A Priority: Normal
NCT ID: NCT00697775 Org: User:
Start: 03/31/98 End: - Due: -

Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' Human Papillomavirus (HPV) Vaccine (GSK-580299) and Merck's Gardasil Vaccine When Administered According to Alternative 2-dose Schedules in 9-14 Year Old Females

Phase: N/A Priority: Normal
NCT ID: NCT01462357 Org: User:
Start: 11/21/11 End: 10/27/15 Due: 10/27/16

Efficacy And Safety Of GW642444M Comparing Placebo In Adolescent And Adult Subjects With Persistent Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT00600171 Org: User:
Start: 12/31/07 End: 09/30/08 Due: 09/30/09

Healthy Volunteer Study Using 3 Different Formulations of Firategrast

Phase: N/A Priority: Normal
NCT ID: NCT01416363 Org: User:
Start: 05/20/11 End: 09/17/11 Due: 09/17/12

Respiratory Syncytial Virus (RSV) Investigational Vaccine in Infants Aged 6 and 7 Months Likely to be Unexposed to RSV

Phase: N/A Priority: Normal
NCT ID: NCT03636906 Org: User:
Start: 04/08/19 End: 07/22/21 Due: 07/22/22

Retapamulin Versus Placebo in Secondarily-Infected Traumatic Lesions (SITL)

Phase: N/A Priority: Normal
NCT ID: NCT00684177 Org: User:
Start: 05/31/08 End: 10/31/09 Due: 10/31/10

A Study to Evaluate Efficacy and Safety of Gepotidacin in the Treatment of Uncomplicated Urinary Tract Infection (UTI)

Phase: N/A Priority: Normal
NCT ID: NCT04020341 Org: User:
Start: 10/17/19 End: 11/30/22 Due: 11/30/23

Incidence of Influenza, Downstream Complications of Influenza & Hospitalizations in Elderly Vaccinated With Fluarix™

Phase: N/A Priority: Normal
NCT ID: NCT00306982 Org: User:
Start: 03/31/06 End: 12/31/06 Due: 12/31/07

Study to Assess Safety & Immunogenicity of GSK Biologicals' Boostrix (dTpa) Vaccine vs. Chinese DT Vaccine

Phase: N/A Priority: Normal
NCT ID: NCT00452686 Org: User:
Start: 03/31/07 End: 05/31/07 Due: 05/31/08

A Study to Test the Safety and Effectiveness of GSK5764227, Alone or With Other Treatments, in Participants With Advanced Gastrointestinal Cancers That Cannot be Surgically Removed

Phase: N/A Priority: Normal
NCT ID: NCT06885034 Org: User:
Start: 06/11/25 End: 02/21/28 Due: 02/21/29

Lot Consistency, Immuno, Safety of Meningococcal Vaccine GSK134612 Given With Fluarix™ to 18-55 Year-Old Adults

Phase: N/A Priority: Normal
NCT ID: NCT00453986 Org: User:
Start: 04/09/07 End: 05/21/08 Due: 05/21/09

Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)

Phase: N/A Priority: Normal
NCT ID: NCT06961214 Org: User:
Start: 06/06/25 End: 08/06/29 Due: 08/06/30

Meta-analysis of Orlistat Laboratory Data From Placebo-controlled Clinical Trials

Phase: N/A Priority: Normal
NCT ID: NCT01332448 Org: User:
Start: 02/28/10 End: 08/31/10 Due: 08/31/11

Rosiglitazone (Extended Release Tablets) As Adjunctive Therapy In Subjects With Mild To Moderate Alzheimer's Disease

Phase: N/A Priority: Normal
NCT ID: NCT00348140 Org: User:
Start: 07/12/06 End: 03/20/09 Due: 03/20/10